[Hepatitis C and alcohol].
Perlemuter
Gabriel
G
Service des maladies du foie et de l'appareil digestif, Hôpital et CHU Bicêtre, 78, rue du Général-Leclerc 94275 Le Kremlin-Bicêtre.
D000410:Alanine Transaminase / Q000097:blood; D000437:Alcoholism / Q000150:complications*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017209:Apoptosis; D001706:Biopsy; D006528:Carcinoma, Hepatocellular / Q000209:etiology; D004796:Clinical Enzyme Tests; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology / Q000473:pathology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008103:Liver Cirrhosis / Q000209:etiology; D008113:Liver Neoplasms / Q000209:etiology; D008297:Male; D016017:Odds Ratio; D015995:Prevalence; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D013997:Time Factors; D019562:Viral Load
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons; D000410:Alanine Transaminase